Text Brad06 + £ Amount to 70070

Siobhan Mather

On 1st May 2015 a beautiful angel was born, Siobhan Margaret Mather. She bought fun and feistiness with her independent character to everyone around her. On 1st July 2017, aged just 2, Siobhan became lethargic and was taken to her GP. After being referred to Barnet General Hospital, it was discovered she had a tumour. She was transferred to Great Ormond Street Hospital (GOSH) where she was diagnosed with Stage 4 Neuroblastoma, a rare child cancer. Neuroblastoma is a very rare cancer and only 100 children per year are diagnosed in the U.K.    Siobhan is in the early stages of her chemotherapy treatment at the amazing GOSH, but still has a long way to go!  She is the bravest 2-year-old girl and is taking everything that this terrible disease can throw at her in her stride.    High-risk neuroblastoma has a high chance of relapse; and relapsed Neuroblastoma has low survival rates.  Relapsed Neuroblastoma is the most dangerous form of the disease. There is no standard relapse protocol for relapsed Neuroblastoma, which means clinical trials are often the only hope for many children.  Such clinical trials are rarely available via the NHS, so where families wish to access this treatment, their only option is abroad, in the hope of helping them beat cancer.  In the USA, there have been a number of trials with high success rates.  The cost for the course of treatment, as well as the associated costs of travelling abroad to access it are estimated in the region of £220,000.

 

 

Terms and Conditions
All cash donations are held by BLF in restricted funds for Siobhan’s campaign.
All fees are paid for by BLF general funds.
BLF will hold funds on behalf of Siobhan and pay invoices directly.
In the event of the child not needing funds raised, BLF will retain 50% of the funds raised for their general charitable purposes such as grant making, fees for funding platforms etc
Parents will then be given a choice to donate the remaining 50% to an already registered children’s charity of their choice.